A detailed history of Aqr Capital Management LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Aqr Capital Management LLC holds 19,636 shares of CDXC stock, worth $146,091. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,636
Holding current value
$146,091
% of portfolio
0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.51 - $3.8 $49,286 - $74,616
19,636 New
19,636 $71,000
Q3 2022

Nov 14, 2022

SELL
$1.19 - $2.06 $185,916 - $321,837
-156,232 Reduced 67.11%
76,571 $94,000
Q2 2022

Aug 15, 2022

SELL
$1.59 - $2.7 $287,767 - $488,662
-180,986 Reduced 43.74%
232,803 $389,000
Q1 2022

May 16, 2022

BUY
$2.02 - $3.92 $366,343 - $710,923
181,358 Added 78.03%
413,789 $1.02 Million
Q4 2021

Feb 14, 2022

BUY
$3.74 - $6.7 $226,606 - $405,953
60,590 Added 35.26%
232,431 $869,000
Q3 2021

Nov 15, 2021

BUY
$6.05 - $10.41 $337,916 - $581,440
55,854 Added 48.16%
171,841 $1.08 Million
Q2 2021

Aug 16, 2021

BUY
$6.66 - $10.92 $257,409 - $422,058
38,650 Added 49.98%
115,987 $1.14 Million
Q1 2021

May 17, 2021

SELL
$4.59 - $18.74 $374,355 - $1.53 Million
-81,559 Reduced 51.33%
77,337 $722,000
Q4 2020

Feb 16, 2021

BUY
$3.93 - $5.5 $69,541 - $97,322
17,695 Added 12.53%
158,896 $763,000
Q3 2020

Nov 16, 2020

BUY
$4.01 - $5.56 $566,216 - $785,077
141,201 New
141,201 $566,000
Q4 2019

Feb 14, 2020

SELL
$2.83 - $4.61 $65,157 - $106,140
-23,024 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$3.83 - $4.72 $88,181 - $108,673
23,024 New
23,024 $91,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $509M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.